Please select your Region.
Please select your Region.
May 28, 2013
ARKRAY, Inc. (herein ’ARKRAY’) will establish a new factory (ARKRAY Ltd.) in Dubna City near Moscow in the Russian Federation and will start production of meters and sensors for the self-monitoring of blood glucose (BGM) prior to shipment into the Russian market.
The Russian in vitro diagnostic market is expanding due to the ageing of society and an increase in lifestyle diseases. In 2012, the Russian diabetic population numbered 12.69 million (the fifth largest in the world) and is expected to reach 14.11 million by 2030*. As a result, ARKRAY is looking to increase supply of medical devices, starting with BGM, into the Russian market and to accelerate global expansion in this, an important and growing market.
ARKRAY has production facilities in 5 countries: Japan (Shiga, the mother factory), China (Shanghai), the U.S. (Minnesota), UK and the Philippines and distributes products in over 80 countries.
The start of operations in the new Russian factory will allow for the production and supply of product for the Russian market and will enable us to meet customer needs faster.
ARKRAY looks to build on its production base and strengthen its customer service so we can match our products with market needs and trends in each country and to speed up our product supply.
*) Source: International Diabetes Federation
| Company name |  |
|---|---|
| Address | 4, Programmistov St., Dubna, Moscow Region 141983, RUSSIA tel: +7-499-703-34-92 fax: +7-496-219-10-14 |
| Shipment start | 27 June 2013 |
| Total area | Approx 572m2 |
| Business type | Development and production of self-monitoring blood glucose meters and sensors |
沪公网安备 31011502009006号
